CD274 and cancer: Cancer cells can resist PD-1/PD-L1 checkpoint inhibition by blocking ferroptosis through the regulation of ferritin and other proteins (24), indicating that activation of the ferroptosis pathway in these cells can sensitize them to PD-1/PD-L1 blockers.